INS and Hyperglycemia: Together, our data are consistent with placentally derived kisspeptin in the maternal circulation exerting an effect on maternal β cells during pregnancy to facilitate enhanced glucose-induced insulin secretion and increase β cell mass to compensate for maternal insulin resistance, thus avoiding overt hyperglycemia.